Regeneron Collaborations on Dupixent® (dupilumab) Highlighted During Sanofi R&D Investor EventPRNewsWire • 06/11/20
Regeneron: Favorable Performance Of Current Product Portfolio, Impressive Pipeline Bode Well For Growth Over The Next DecadeSeeking Alpha • 06/04/20
Jeff Reeves's Strength in Numbers: Buy this, not that — 5 stocks to trade into now and 5 to avoidMarket Watch • 06/03/20
Regeneron Pharmaceuticals, Inc. (REGN) Regeneron Oncology Investor Event, ASCO 2020 Conference (Transcript)Seeking Alpha • 06/02/20
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Regeneron Oncology Investor Event ASCO 2020 Conference (Transcript)Seeking Alpha • 06/02/20
Regeneron Pharmaceuticals, Inc. (REGN) CEO Len Schleifer Presents at Bernstein's 36th Annual Strategic Decisions Conference (Transcript)Seeking Alpha • 05/30/20
Libtayo® (cemiplimab-rwlc) Longer-term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ASCO 2020 Show Durable Responses that Deepen Over TimePRNewsWire • 05/29/20
Regeneron's Dupixent Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 05/28/20